Improved metabolic syndrome-related right and left ventricular dysfunction by the dual ETA-ETB receptor antagonist macitentan.
Event:
Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic:
Pulmonary hypertension
Session:
Basic science - Animal experimentation